Per Ljungman

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (17)

Grzegorz Władysław Basak

University Clinical Centre

POLAND

View details

Rafael de la Camara

- Head of Haematology

Hospital Universitario Virgen del Rocío

SPAIN

View details

Ibrahim Yakoub-Agha

Professeur des Universités - Praticien Hospitalier

Centre Hospitalier Régional Universitaire de Lille

FRANCE

View details

Elinor Nemlander

Karolinska Institutet

SWEDEN

View details

Hans H. Hirsch

SWITZERLAND

View details

Gustaf Edgren

Karolinska Institutet

SWEDEN

View details

Fareed Khawaja

Assistant professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jan Styczyński

POLAND

View details

MALGORZATA MIKULSKA

University of Genoa

ITALY

View details

Jaime Sanz

Profesor asociado asistencial

Universidad Católica de Valencia Facultad de Medicina

SPAIN

View details

Johan Richter

Professor

Lund University

SWEDEN

View details

Michael J. Boeckh

University of Washington

UNITED STATES

View details

Leif Stenke

SWEDEN

View details

Diana Averbuch

ISRAEL

View details

Achilles Anagnostopoulos

Chief Scientific Director

GREECE

View details

Johan Nordgren

Linköping University

SWEDEN

View details

Nina Worel

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Per Ljungman

Research Interests

Explore related searches

Contact this professor

Articles (20)

The Stockholm early detection of cancer study (STEADY-CAN): rationale, design, data collection, and baseline characteristics for 2.7 million participants

Do not forget vaccinations in patients on Ig replacement

Author’s Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10)

Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th European Conference on Infections in Leukaemia

Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum

Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Vaccination of Adults With Cancer: ASCO Guideline

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy

Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)

Long-Term Immunity Against Tetanus and Diphtheria after Vaccination of Allogeneic Stem Cell Transplantation Recipients

New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Pary of EBMT

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

The Importance of Secretor-Status in Norovirus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation

Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)

Cancer incidence in healthy Swedish peripheral blood stem cell donors

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study

Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT

Collaborators (17)

Grzegorz Władysław Basak

Rafael de la Camara

Ibrahim Yakoub-Agha

Elinor Nemlander

Hans H. Hirsch

Gustaf Edgren

Fareed Khawaja

Jan Styczyński

MALGORZATA MIKULSKA

Jaime Sanz

Johan Richter

Michael J. Boeckh

Leif Stenke

Diana Averbuch

Achilles Anagnostopoulos

Johan Nordgren

Nina Worel

Make your next move.